Physician profile
Elizabeth Settle
NPI 1972086775
$928.83
in general payments reported to CMS, 2019-2025
13 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $52.38 · 2023: $197 · 2024: $526 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $841 · Education: $35.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $840.50 |
| Education | $35.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $276.07 | 2024-2025 | Activ.A.C., Kerramax Care, Promogran Prisma |
| Abbvie INC. | $249.12 | 2022-2024 | |
| Argenx US, INC. | $63.26 | 2023 | Vyvgart |
| Takeda Pharmaceuticals U.S.A., INC. | $61.30 | 2024 | Hyqvia |
| Pfizer INC. | $61.20 | 2023-2024 | |
| Sk Life Science, INC. | $49.56 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $33.55 | 2024 | |
| Ucb, INC. | $29.42 | 2024 | Rystiggo |
| Axsome Therapeutics, INC. | $27.26 | 2025 | Symbravo |
| Csl Behring | $27.15 | 2024 | Hizentra |
| Eisai INC. | $18.43 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $16.59 | 2023 | Austedo Xr |
| Livanova USA, INC. | $15.92 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Settle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.